IRBM, announced a new agreement in the peptide therapeutics area with Merck & Co. Inc., Kenilworth NJ USA, known as MSD outside the United States and Canada, continuing their long-standing history of collaboration that began in 2010. “Our R&D peptide group have extensive expertise to help deliver high quality peptide drugs for a wide variety…